Mitochondrial DNA Point Mutation T9176C in Leigh Syndrome

Abstract

Leigh syndrome is a progressive neurodegenerative disease frequently associated with mitochondrial abnormalities. The mitochondrial DNA T9176C mutation in the adenosine triphosphatase 6 gene has recently been described as a cause of Leigh syndrome. Leukocyte DNA from 59 children with Leigh syndrome was screened for the T9176C mutation by conventional polymerase chain reaction methods. Two unrelated patients were found to be homoplasmic for this mutation in blood. Both patients had similar clinical and biochemical features. They had first presented acutely at 3 and 5 years, respectively, with ataxia and slurred speech. Magnetic resonance imaging changes were consistent with Leigh syndrome, and the cerebrospinal fluid lactate was elevated. They have both had relatively stable disease since the time of diagnosis. The mother of one of the children had presented at age 29 years with sudden onset of ataxia, headache, and blurred vision. She was heteroplasmic for the T9176C mutation. The T1976C is an important cause of Leigh syndrome especially in the subgroup of patients with more stable disease and normal respiratory chain enzyme analysis. (J Child Neurol 2000; 15:830-833).

Get full access to this article

View all access options for this article.

References

Shoffner JM , Wallace DC : Oxidative phosphorylation diseases, in Scriver CR , Beaudet Al , Sly WS , Valle D (eds): The Metabolic and Molecular Basis of Inherited Disease. New York, McGraw-Hill, 1995, 1535-1587.

Rahman S. , Blok RB , Dahl Hhm , et al: Leigh syndrome: Clinical features and biochemical and DNA abnormalities . Ann Neurol 1995;39: 343-351.

Morris Aam , Leonard JV , Brown GK , et al: Deficiency of respiratory chain complex I is a common cause of Leigh disease. Ann Neurol 1996; 40:25-30.

Tatuch Y. , Christodoulou J. , Feigenbaum A. , et al: Heteroplasmic mtDNA mutation at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992;50:852-858.

Thyagarajan D. , Shanske S. , Vazquez-Memije M. , et al: A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neuro L 1995;38:468-472.

Campos Y. , Martin MA , Rubio JC , et al. Leigh syndrome associated with the T9176C mutation in the ATPase 6 gene of mitochondrial DNA. Neurology 1997 ;49:595-597.

Makino M. , Horat S. , Goto Y. , Nonaka I. : Confirmation that a T-to-C mutation is an additional candidate mutation for Leigh's syndrome. Neuromusc Disord 1998;8:149-151.

De Meirleir L , Seneca S. , Lissens W. , et al: Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene. Pediatr Neurol 1995;13:242-246.

Hartzog PE , Cain BD: The aleu207-arg mutation in F1F0-ATP synthase from Escherichia coli. A model for human mitochondrial disease. J Biol Chem 1993;268:12250-12252.

10.

Dionisi-Vici C. , Seneca S. , Zeviani M. , et al: Fulminant Leigh syndrome and unexpected death in a family with the T9176C mutation of the mitochondrial ATPase 6 gene . J Inherit Metab Dis 1998;19:43-50.

11.

Trounce I. , Neill S. , Wallace DC : Cytoplasmic transfer of the mtDNA 8993 T—>G (ATP6) mutation associated with Leigh syndrome into mtDNA— less cells demonstrates cosegregation with a decrease in state II respiration and ADP/0 ratio. Proc Natl Acad Sci U S A 1994;91:8334-8338.

12.

de-Vries DD , van-Engelen BG , Gabreels FJ , et al: A second missense mutation in the mitochondrial ATPase gene in Leigh's syndrome. Ann Neurol 1993;34:410-412.

13.

Santorelli FM , Mak SC , Vazquez Memije E. , et al: Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatr Res 1996;39:914-917.